Our Clinic
IN-VIVO is a multi-specialty Clinical Research Center founded in 2017 in Bydgoszcz, Poland. Conducting Phase II through Phase IV studies in a large variety of medical specialties.
We have experience conducting clinical trials
in many therapeutic areas, particularly..
Infectious disease
(prevention and treatment of children, adolescents and adults), caused by e.g.:
Meningococci
Pneumococci
COVID-19
Influenza
Varicella
Respiratory Syncytial Virus (RSV)
Diabetology
Type 1 and type 2 diabetes
Diabetic retinopathy
Diabetic nephropathy
Overweight & obesity
Gynecology
Endometriosis
Uterine myoma
Vasomotor symptoms associated with menopause
Gynecological oncology
Fertility disorders
Cardiology
Cardiac arrhythmias
Hypertension
Prevention of cardiovascular events in high-risk patients
Cardiac failure
Orthopedics
Degeneration of the spine
Pain syndrome
Pediatrics & Neonatology
Allergies (e.g. hypoallergenic modified milks)
Skin diseases
Gastrointestinal diseases (GERD, treatment prevents regurgitation)
Anemia
Psychiatry
Depression
Post Traumatic Stress Disorder (PTSD)
Bipolar disorder
Schizophrenia
Urology
Uro-oncology
Erection disorders
Micturition disorder, including urinary incontinence
The personnel responsible for the collection, preparation and shipment of biological material regularly participate in IATA training
All members of the team are required to follow ICH GCP requirements, EU, Polish legislation and Company’s Standard Operating Procedures (SOPs)
Anna Nodewald
Administrative manager
Organizational matters
Independent Ethics Committee (IEC)
N-VIVO belongs to IEC at the medical council in Bydgoszcz. The committee meets a regular intervals every 4 weeks.
Contract
A quick, efficient process. The average duration of time, from starting negotiations to signing the contract is 28 days.
Inspections and Audits
Since 2020 IN-VIVO has underwent 7 audits. The Principal Investigators who cooperate with our Center have experience in FDA, Polish routine regulatory inspections and audits.